Ra Bermel

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. ncbi Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study
    R A Bermel
    Department of Neurology, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH 44195, USA
    Mult Scler 16:588-96. 2010
  2. ncbi Diagnosing multiple sclerosis at a later age: more than just progressive myelopathy
    Robert A Bermel
    Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, USA
    Mult Scler 16:1335-40. 2010

Detail Information

Publications2

  1. ncbi Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study
    R A Bermel
    Department of Neurology, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH 44195, USA
    Mult Scler 16:588-96. 2010
    ....
  2. ncbi Diagnosing multiple sclerosis at a later age: more than just progressive myelopathy
    Robert A Bermel
    Mellen Center for MS Treatment and Research, Cleveland Clinic, Cleveland, OH, USA
    Mult Scler 16:1335-40. 2010
    ..In this study we review our experience with patients diagnosed at age 60 or over, with particular emphasis on patients who continue to have evidence of active inflammation despite a later onset...